BREAKING

Imperial Petroleum (IMPP) Q4 Earnings Surge 250% YoY to $0.35 EPS on Strong Tanker Utilization 7 hours ago Victoria’s Secret (VSCO) Reports Q4 Adj. Earnings of $2.77/Share, up 6.5% 9 hours ago Algonquin Reports Q4FY25 Earnings Rebound on Utility Growth 10 hours ago Myers Industries (MYE) Q4 Adjusted EPS Surges 63% to $0.31 on Margin Expansion 10 hours ago Embraer backlog hits record $31.6B as deliveries surge in Q4FY25 11 hours ago Capital Clean Energy Carriers (CCEC) Reports Q4 EPS of $0.48 on $98.3M Revenue 11 hours ago Genesco Q4 FY26 Results Show Strong Nine Percent Comp Growth 11 hours ago Kura Oncology Reports $0.92 Q4 Loss Even as KOMZIFTI Debuts With $2.1M in Sales 11 hours ago Autohome (ATHM) Q4 Earnings Meet Estimates at $0.09 EPS Despite Revenue Plunge to $209M 12 hours ago Global Ship Lease (GSL) Q4 Adjusted EPS Drops 9 % to $2.32, EBITDA Hits $124.7M 12 hours ago Imperial Petroleum (IMPP) Q4 Earnings Surge 250% YoY to $0.35 EPS on Strong Tanker Utilization 7 hours ago Victoria’s Secret (VSCO) Reports Q4 Adj. Earnings of $2.77/Share, up 6.5% 9 hours ago Algonquin Reports Q4FY25 Earnings Rebound on Utility Growth 10 hours ago Myers Industries (MYE) Q4 Adjusted EPS Surges 63% to $0.31 on Margin Expansion 10 hours ago Embraer backlog hits record $31.6B as deliveries surge in Q4FY25 11 hours ago Capital Clean Energy Carriers (CCEC) Reports Q4 EPS of $0.48 on $98.3M Revenue 11 hours ago Genesco Q4 FY26 Results Show Strong Nine Percent Comp Growth 11 hours ago Kura Oncology Reports $0.92 Q4 Loss Even as KOMZIFTI Debuts With $2.1M in Sales 11 hours ago Autohome (ATHM) Q4 Earnings Meet Estimates at $0.09 EPS Despite Revenue Plunge to $209M 12 hours ago Global Ship Lease (GSL) Q4 Adjusted EPS Drops 9 % to $2.32, EBITDA Hits $124.7M 12 hours ago

ADVERTISEMENT

LX

LXRX

All LXRX Content

7 articles, transcripts, and reports

Analysis

Lexicon Pharmaceuticals (LXRX) Q4 Loss Narrows to $0.04 Per Share Despite 79% Revenue Plunge to $5.5M

Lexicon narrows Q4 loss to $0.04 per share from $0.09 year-ago, but revenue plunges 79% to $5.5M amid commercialization challenges.

March 6, 20262 min read

Breaking News

LXRX Reports Mixed Q4 Results: Loss Improves to $0.04 Per Share But Revenue Crashes 79% YoY

Lexicon narrows Q4 loss to $0.04 per share, down 55.6% YoY, but revenue plunges 79% to $5.5M amid biotechnology sector headwinds.

March 6, 20261 min read

Lexicon Pharmaceuticals, inc (LXRX) Q2 2022 Earnings Call

Lexicon Pharmaceuticals, inc (NASDAQ: LXRX) Q2 2022 Earnings Conference

August 1, 20221 min read

Lexicon Pharmaceuticals, inc (LXRX) Q1 2022 Earnings Call

Lexicon Pharmaceuticals, inc (NASDAQ: LXRX) Q1 2022 Earnings Conference

May 2, 20221 min read

Lexicon Pharmaceuticals, inc (LXRX) Q3 2021 earnings conference call

Lexicon Pharmaceuticals, inc (NASDAQ: LXRX) Q3 2021 Earnings Conference

November 8, 20211 min read

Lexicon Pharmaceuticals, inc (LXRX) 2Q21 Earnings Call

Lexicon Pharmaceuticals, inc (NASDAQ: LXRX) Q2 2021 Earnings Conference

August 2, 20211 min read

Lexicon Pharmaceuticals (NASDAQ: LXRX) Q1 2020 Earnings Call Transcript

Lexicon Pharmaceuticals (LXRX) Q1 2020 earnings call dated Apr. 27, 2020 Corporate Participants: Kimberly Lee — Head of Investor Relations and Corporate Strategy Lonnel Coats — President and Chief…

April 27, 202027 min read